METASTATIC COLORECTAL CANCER
Clinical trials for METASTATIC COLORECTAL CANCER explained in plain language.
Never miss a new study
Get alerted when new METASTATIC COLORECTAL CANCER trials appear
Sign up with your email to follow new studies for METASTATIC COLORECTAL CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Doctors test custom drug cocktails to outsmart spreading colon cancer
Disease control Not yet recruitingThis early-phase study aims to control metastatic colorectal cancer by testing personalized drug combinations tailored to each patient's tumor characteristics. Researchers will enroll 100 adults with advanced colon cancer that has spread, using biopsies to identify resistance mar…
Matched conditions: METASTATIC COLORECTAL CANCER
Phase: EARLY_PHASE1 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Mar 31, 2026 12:12 UTC
-
New Two-Drug attack aims to shrink tough colon cancer tumors before surgeons operate
Disease control Not yet recruitingThis early-stage trial is testing whether giving two immunotherapy drugs before surgery can help people with a common type of colorectal cancer that has spread to the liver. The goal is to see if this drug combination is safe and if it can shrink the liver tumors, which might lea…
Matched conditions: METASTATIC COLORECTAL CANCER
Phase: PHASE1, PHASE2 • Sponsor: Dan Feng • Aim: Disease control
Last updated Mar 25, 2026 14:07 UTC
-
Targeted radiation therapy trial offers hope for advanced colon cancer patients
Disease control Not yet recruitingThis early-stage study is testing a new targeted radiation therapy for people with metastatic colorectal cancer that has stopped responding to standard treatments. The therapy uses radioactive particles that specifically seek out and attach to cancer cells. Researchers will first…
Matched conditions: METASTATIC COLORECTAL CANCER
Phase: PHASE1 • Sponsor: Hoffmann-La Roche • Aim: Disease control
Last updated Mar 23, 2026 15:16 UTC
-
New cancer drug combo trial aims to slow tumor growth better than current standard
Disease control Not yet recruitingThis study is testing whether adding a new drug called ivonescimab to standard chemotherapy works better than the current standard combination for people with advanced colorectal cancer that hasn't spread to the liver. Researchers will compare how long each treatment keeps the ca…
Matched conditions: METASTATIC COLORECTAL CANCER
Phase: PHASE2 • Sponsor: UNICANCER • Aim: Disease control
Last updated Mar 10, 2026 12:53 UTC